Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Lung Cancer

  • You have access
    Epithelial-mesenchymal transition-related circular RNAs in lung carcinoma
    Meina Jiang, Shuai Fang, Xiaodong Zhao, Chengwei Zhou and Zhaohui Gong
    Cancer Biology & Medicine May 2021, 18 (2) 411-420; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0238
  • You have access
    Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
    Zhen Zhou, Zichuan Liu, Qiuxiang Ou, Xue Wu, Xiaonan Wang, Yang Shao, Hongyan Liu and Yu Yang
    Cancer Biology & Medicine May 2021, 18 (2) 490-501; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0120
  • You have access
    A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma
    Qiujuan Huang, Tongyuan Qu, Lisha Qi, Changxu Liu, Yuhong Guo, Qianru Guo, Guangning Li, Yalei Wang, Wenshuai Zhang, Wei Zhao, Danyang Ren, Leina Sun, Shengguang Wang, Bin Meng, Baocun Sun, Bin Zhang, Wenjuan Ma and Wenfeng Cao
    Cancer Biology & Medicine May 2021, 18 (2) 517-529; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0648
  • You have access
    Competing endogenous RNAs in lung cancer
    Meilian Zhao, Jianguo Feng and Liling Tang
    Cancer Biology & Medicine February 2021, 18 (1) 1-20; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0203
  • You have access
    Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer
    Jun Zhang, Bei Sun, Xianhui Ruan, Xiukun Hou, Jingtai Zhi, Xiangrui Meng, Xiangqian Zheng and Ming Gao
    Cancer Biology & Medicine February 2021, 18 (1) 105-119; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0098
  • You have access
    Morphine-3-glucuronide upregulates PD-L1 expression via TLR4 and promotes the immune escape of non-small cell lung cancer
    Kaiyuan Wang, Jian Wang, Ting Liu, Wenwen Yu, Nan Dong, Chen Zhang, Wenbin Xia, Feng Wei, Lili Yang and Xiubao Ren
    Cancer Biology & Medicine February 2021, 18 (1) 155-171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0442
  • You have access
    Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity
    Xuanming Chen, Cheng Shen, Zhe Wei, Rui Zhang, Yongsheng Wang, Lili Jiang, Ke Chen, Shuang Qiu, Yuanli Zhang, Ting Zhang, Bin Chen, Yanjun Xu, Qiyi Feng, Jinxing Huang, Zhihui Zhong, Hongxia Li, Guowei Che and Kai Xiao
    Cancer Biology & Medicine February 2021, 18 (1) 184-198; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0012
  • You have access
    The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai, Jian Zhang, Yaru Tian, Ji Li, Wang Jing, Hongbo Guo and Hui Zhu
    Cancer Biology & Medicine August 2020, 17 (3) 599-611; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0102
  • You have access
    Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling
    Tingting Qin, Zhujun Liu, Jing Wang, Junling Xia, Shaochuan Liu, Yanan Jia, Hailin Liu and Kai Li
    Cancer Biology & Medicine August 2020, 17 (3) 753-767; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0024
  • You have access
    Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer
    Runsen Jin, Chengming Liu, Sufei Zheng, Xinfeng Wang, Xiaoli Feng, Hecheng Li, Nan Sun and Jie He
    Cancer Biology & Medicine August 2020, 17 (3) 768-781; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0121

Pages

  • Next
  • 1
  • 2
  • Health Services
    • Cardiology
  • Breast Cancer (15)
  • Lung Cancer (18)
  • Gastrointestinal Cancer (13)
  • Cancer Microenvironment (9)
  • Brain Tumor (10)
  • Cancer Epidemiology (7)

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire